DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Slamon D, Gomez HL, Kabbinavar FF. et al
Randomized study of pazopanib + lapatinib vs. lapatinib alone in patients with HER2- positive advanced or metastatic breast cancer.
J Clin Oncol 2008; 26 (Suppl.): Abstr. 1016-
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.